| P2093 | author name string | Jaroslav Pelisek | |
| | Sigrid Nikol | |
| | Constanze Veronika Redl | |
| | Corinna Barz | |
| | Juergen Heesemann | |
| | Markus Georg Engelmann | |
| P2860 | cites work | Low-density lipoprotein receptor-deficient mice are protected against lethal endotoxemia and severe gram-negative infections | Q24562428 |
| | Chlamydia pneumoniae induces aponecrosis in human aortic smooth muscle cells | Q24798576 |
| | A mouse model of Chlamydia pneumoniae strain TWAR pneumonitis | Q33596734 |
| | Chlamydial and human heat shock protein 60s activate human vascular endothelium, smooth muscle cells, and macrophages | Q33842925 |
| | The atherogenic effects of chlamydia are dependent on serum cholesterol and specific to Chlamydia pneumoniae | Q33843538 |
| | Chlamydia pneumoniae infection promotes a proliferative phenotype in the vasculature through Egr-1 activation in vitro and in vivo | Q33927267 |
| | Chlamydia pneumoniae-induced atherosclerosis in a rabbit model | Q33935073 |
| | Chlamydia pneumoniae antigens, rather than viable bacteria, persist in atherosclerotic lesions | Q35395485 |
| | Chlamydia pneumoniae infections in mouse models: relevance for atherosclerosis research | Q36003606 |
| | Identification of a new group of Chlamydia psittaci strains called TWAR. | Q37213605 |
| | Heat-inactivated C. pneumoniae organisms are not atherogenic. | Q37866854 |
| | Effect of short-term treatment with azithromycin on recurrent ischaemic events in patients with acute coronary syndrome in the Azithromycin in Acute Coronary Syndrome (AZACS) trial: a randomised controlled trial | Q37869839 |
| | Chlamydial heat-shock protein-60 antibody and correlation with Chlamydia pneumoniae in atherosclerotic plaques | Q37870954 |
| | Chlamydophila pneumoniae (Chlamydia pneumoniae) accelerates the formation of complex atherosclerotic lesions in Apo E3-Leiden mice | Q37870991 |
| | Effect of azithromycin treatment on endothelial function in patients with coronary artery disease and evidence of Chlamydia pneumoniae infection | Q37872325 |
| | Chlamydia pneumoniae infection accelerates the progression of atherosclerosis in apolipoprotein E-deficient mice | Q37878302 |
| | Randomized secondary prevention trial of azithromycin in patients with coronary artery disease and serological evidence for Chlamydia pneumoniae infection: The Azithromycin in Coronary Artery Disease: Elimination of Myocardial Infection with Chlamyd | Q37878769 |
| | Is infection with Chlamydia pneumoniae a causative agent in atherosclerosis? | Q37879915 |
| | A Chlamydia pneumoniae component that induces macrophage foam cell formation is chlamydial lipopolysaccharide | Q37879971 |
| | Chlamydial heat shock protein 60 localizes in human atheroma and regulates macrophage tumor necrosis factor-alpha and matrix metalloproteinase expression | Q37880399 |
| | Endovascular presence of viable Chlamydia pneumoniae is a common phenomenon in coronary artery disease | Q37881317 |
| | Infection with Chlamydia pneumoniae accelerates the development of atherosclerosis and treatment with azithromycin prevents it in a rabbit model | Q37881464 |
| | Endovascular presence of Chlamydia pneumoniae in patients with hemodynamically effective carotid artery stenosis | Q37882356 |
| | Chlamydia in coronary plaques--hidden culprit or harmless hobo? | Q37884682 |
| | Increased incidence of Chlamydia species within the coronary arteries of patients with symptomatic atherosclerotic versus other forms of cardiovascular disease | Q37884972 |
| | Systemic dissemination of Chlamydia pneumoniae following intranasal inoculation in mice | Q37887366 |
| | Experimental infection of Chlamydia pneumoniae in mice | Q37890203 |
| | Demonstration of Chlamydia pneumoniae in atherosclerotic lesions of coronary arteries | Q37891287 |
| | Detection of Chlamydia pneumoniae by polymerase chain reaction | Q37893831 |
| | Experimental infection of baboons (Papio cynocephalus anubis) with Chlamydia pneumoniae strain 'TWAR'. | Q37898047 |
| | Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction | Q37899465 |
| | A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. | Q40467498 |
| | Immunopathogenesis of atherosclerosis: endotoxin accelerates atherosclerosis in rabbits on hypercholesterolemic diet | Q40597623 |
| | Lipopolysaccharide stimulation of RAW 264.7 macrophages induces lipid accumulation and foam cell formation | Q41579091 |
| | Phagocyte function in familial hypercholesterolaemia: peripheral blood monocytes exposed to lipopolysaccharide show increased tumour necrosis factor production. | Q54705155 |
| | Recurrent perivascular inflammation induced by lipopolysaccharide (endotoxin) results in the formation of atheromatous lesions in vivo | Q76341995 |
| | Increased interleukin-1alpha and interleukin-1beta production by macrophages of low-density lipoprotein receptor knock-out mice stimulated with lipopolysaccharide is CD11c/CD18-receptor mediated | Q77586807 |
| | LPS-induced cytokine production and expression of beta2-integrins and CD14 by peripheral blood mononuclear cells of patients with homozygous familial hypercholesterolemia | Q77718641 |
| P433 | issue | 5 | |
| P921 | main subject | Chlamydophila pneumoniae | Q132319 |
| P304 | page(s) | 467-476 | |
| P577 | publication date | 2006-05-01 | |
| P1433 | published in | Laboratory Investigation | Q6467260 |
| P1476 | title | Chronic perivascular inoculation with Chlamydophila pneumoniae results in plaque formation in vivo | |
| P478 | volume | 86 | |